About
Science
Pipeline
Jobs
News
News
Read the latest from HI-Bio™
All
News
November 1, 2022
Armed with $120M, HI-Bio joins race to develop better autoimmune disease drugs
News
November 1, 2022
Arch-backed HI-Bio launches with 2 clinical-stage therapies from MorphoSys and $120M in cash
Press Releases
November 1, 2022
Human Immunology Biosciences Launches to Lead Clinical Immunology into Its Next Chapter with $120 Million Financing
Press Releases
June 14, 2022
MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
1
Contact Us
info@hibio.com